SEARCH

SEARCH BY CITATION

References

  • 1
    Ewe K, Herfarth C, Malchow H, Jedinsky JH. Postoperative recurrence of Crohn’s disease in relation to radicality of operation and sulfasalazine prophylaxis. Digestion 1989; 42: 224 32.
  • 2
    Gendre JP, Mary JY, Florent C, et al. Oral mesalamine (Pentasa) as maintenance treatment in Crohn’s disease: a multicenter placebo-controlled study. Gastroenterology 1993; 104: 435 9.
  • 3
    Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540 9.
  • 4
    Singleton JW, Hanauer SB, Gitnick GL, et al. Mesalamine capsules for the treatment of active Crohn’s disease: results of a 16-week trial. Gastroenterology 1993; 103: 1293 301.
  • 5
    Hanauer S, Schwartz J, Robinson M, et al. Mesalamine capsules for treatment of active ulcerative colitis: Results of a controlled trial. Am J Gastroenterol 1993; 88: 1188 97.
  • 6
    Ewe K. Morbus Crohn und Colitis ulcerosa—neue Therapieansätze. Z Gastroenterol 1993; 31: 151 5.
  • 7
    Vernia P, Gnaedinger A, Hauck W, Breuer RI. Organic anions and the diarrhoea of inflammatory bowel disease. Dig Dis Sci 1988; 33: 1353 8.
  • 8
    Vernia P, Latella RCG, Barbetti F, Magliocca FM, Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988; 95: 1564 8.
  • 9
    Fallingborg J, Christensen LA, Jacobson BA, Rasmussen SN. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig Dis Sci 1993; 38: 1989 93.
  • 10
    Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 92 5.
  • 11
    Best WR, Becktel JM, Singleton JW, Kern F Jr Development of a Crohn’s disease activity index. Natl Cooperative Crohn’s Dis Study. Gastroenterol 1976; 70: 439 44.
  • 12
    Evans DF, Pye G, Bramley R, Clark A, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035 41.
  • 13
    Raimundo AH, Evans DF, Rogers J, Silk DBA. Gastrointestinal pH profiles in ulcerative colitis. Gastroenterology 1992; 102: A 681.
  • 14
    Lewis JD & Fisher RL. Nutrition support in inflammatory bowel disease. Med Clin North Am 1994; 78: 1443 56.
  • 15
    Baixas D, Rigand D, Le-Port J, et al. Dietary behavior and nutritional status of patients with ileorectal anastomosis after colectomy for hemorrhagic rectocolitis. Gastroenterol Clin Biol 1984; 8: 551 6.
  • 16
    Cummings JH. Colonic absorption. The importance of short chain fatty acids in man. Scand J Gastroenterol (Suppl) 1984; 93: 89 99.
  • 17
    Roediger WEW. The colonic epithelium in ulcerative colitis: an energy deficiency disease. Lancet 1980; ii: 712 15.
  • 18
    Perman JA, Modler S, Olson AC. Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora. J Clin Invest 1981; 67: 643 50.
  • 19
    Frieling T, Lübke K, Trampisch HJ, Wienbeck M. pH-Metrie im Verdauungstrakt—Probleme bei der Datenanalyse. Z Gastroenterol 1986; 24: 709 11.
  • 20
    Dube S & Heyen F. Pouchitis and gastric hyposecretion: cause or effect? Int J Colorectal Dis 1990; 5: 142 3.